organization · Reporting owner
Chavant Capital Partners LLC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
MOBIX LABS, INC
Report date December 21, 2023 · Filed December 26, 2023
Section 16 reporting ended · disclosed 2023-12-26. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 1,394,101 |
Last balance in matching sequence
After 2023-12-21 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2023-12-21 · Other · Disposed 658,631 · Balance 922,182 F1: Pursuant to the Issuer's de-registration as a Cayman Islands exempted company and domestication as a Delaware corporation (the "Domestication") in connection with the closing (the "Closing") of the Issuer's initial business combination (the "Business Combination"; the Issuer prior to the Domestication, "Chavant") with Mobix Labs, Inc. (the "Target") on December 21, 2023, each ordinary share of Chavant ("Ordinary Share") and each private placement warrant, exercisable to purchase one Ordinary Share for $11.50 per share, subject to certain adjustments, of Chavant ("Chavant Private Placement Warrants") was automatically converted into one share of Class A Common Stock of the Issuer ("Class A Common Stock") and one private placement warrant, exercisable to purchase one share of Class A Common Stock for $11.50 per share, subject to certain adjustments, of the Issuer ("Private Placement Warrants"), respectively. In connection with the Closing, Chavant was renamed "Mobix Labs, Inc." F2: Represents a forfeiture of 658,631 Ordinary Shares held by the Sponsor in connection with the Closing (the "Share Forfeiture"). Row 2 · 2023-12-21 · Purchase · Acquired 199,737 · Balance 1,121,919 F1: Pursuant to the Issuer's de-registration as a Cayman Islands exempted company and domestication as a Delaware corporation (the "Domestication") in connection with the closing (the "Closing") of the Issuer's initial business combination (the "Business Combination"; the Issuer prior to the Domestication, "Chavant") with Mobix Labs, Inc. (the "Target") on December 21, 2023, each ordinary share of Chavant ("Ordinary Share") and each private placement warrant, exercisable to purchase one Ordinary Share for $11.50 per share, subject to certain adjustments, of Chavant ("Chavant Private Placement Warrants") was automatically converted into one share of Class A Common Stock of the Issuer ("Class A Common Stock") and one private placement warrant, exercisable to purchase one share of Class A Common Stock for $11.50 per share, subject to certain adjustments, of the Issuer ("Private Placement Warrants"), respectively. In connection with the Closing, Chavant was renamed "Mobix Labs, Inc." F3: Pursuant to a Subscription Agreement, the Reporting Person purchased 199,737 shares of Class A Common Stock in connection with the closing of the Business Combination for aggregate consideration of $1,997,370, consisting of the forgiveness of certain indebtedness and certain expense reimbursement obligations owed by the Issuer to the Sponsor and its members (the "PIPE Investment" and such shares, the "PIPE Shares"). In connection with the entry into the Subscription Agreement, the Target issued the Reporting Person a warrant 272,454 warrants to purchase 272,454 shares of common stock of the Target. Such warrant was net exercised for 272,182 shares of common stock of the Target in connection with the closing of the Subscription Agreement, which occurred substantially concurrently with the Closing. Such 272,454 shares of common stock of the Target were automatically converted into 272,182 shares of Class A Common Stock upon the Closing. Row 3 · 2023-12-21 · Other · Acquired 272,182 · Balance 1,394,101 F1: Pursuant to the Issuer's de-registration as a Cayman Islands exempted company and domestication as a Delaware corporation (the "Domestication") in connection with the closing (the "Closing") of the Issuer's initial business combination (the "Business Combination"; the Issuer prior to the Domestication, "Chavant") with Mobix Labs, Inc. (the "Target") on December 21, 2023, each ordinary share of Chavant ("Ordinary Share") and each private placement warrant, exercisable to purchase one Ordinary Share for $11.50 per share, subject to certain adjustments, of Chavant ("Chavant Private Placement Warrants") was automatically converted into one share of Class A Common Stock of the Issuer ("Class A Common Stock") and one private placement warrant, exercisable to purchase one share of Class A Common Stock for $11.50 per share, subject to certain adjustments, of the Issuer ("Private Placement Warrants"), respectively. In connection with the Closing, Chavant was renamed "Mobix Labs, Inc." F3: Pursuant to a Subscription Agreement, the Reporting Person purchased 199,737 shares of Class A Common Stock in connection with the closing of the Business Combination for aggregate consideration of $1,997,370, consisting of the forgiveness of certain indebtedness and certain expense reimbursement obligations owed by the Issuer to the Sponsor and its members (the "PIPE Investment" and such shares, the "PIPE Shares"). In connection with the entry into the Subscription Agreement, the Target issued the Reporting Person a warrant 272,454 warrants to purchase 272,454 shares of common stock of the Target. Such warrant was net exercised for 272,182 shares of common stock of the Target in connection with the closing of the Subscription Agreement, which occurred substantially concurrently with the Closing. Such 272,454 shares of common stock of the Target were automatically converted into 272,182 shares of Class A Common Stock upon the Closing. |
| Private Placement WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $11.50 · Expires 2028-12-21 | Direct | 0 |
Reported balance
After 2023-12-21 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-12-21 · Other · Disposed 2,394,332 · Balance 0 F1: Pursuant to the Issuer's de-registration as a Cayman Islands exempted company and domestication as a Delaware corporation (the "Domestication") in connection with the closing (the "Closing") of the Issuer's initial business combination (the "Business Combination"; the Issuer prior to the Domestication, "Chavant") with Mobix Labs, Inc. (the "Target") on December 21, 2023, each ordinary share of Chavant ("Ordinary Share") and each private placement warrant, exercisable to purchase one Ordinary Share for $11.50 per share, subject to certain adjustments, of Chavant ("Chavant Private Placement Warrants") was automatically converted into one share of Class A Common Stock of the Issuer ("Class A Common Stock") and one private placement warrant, exercisable to purchase one share of Class A Common Stock for $11.50 per share, subject to certain adjustments, of the Issuer ("Private Placement Warrants"), respectively. In connection with the Closing, Chavant was renamed "Mobix Labs, Inc." F4: Represents a pro rata distribution of 2,394,332 Private Placement Warrants to members of the Reporting Person in respect of their indirect interests in such Private Placement Warrants. Such Private Placement Warrants had been held by the Reporting Person as Chavant Private Placement Warrants since the initial public offering of the Issuer. Private Placement Warrants may be exercised 30 days after the Closing and expire five years after Closing or earlier upon liquidation. Balance of securities following the distribution described above reflects the forfeiture of 400,000 Private Placement Warrants in connection with the Closing of the Business Combination. |
| Make-Whole Shares (right to acquire)SEC Table II · derivative / convertible security · Conversion / exercise price $10.00 | Direct | 199,737 |
Reported balance
After 2023-12-21 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2023-12-21 · Other · Acquired 199,737 · Balance 199,737 F5: Pursuant to the Subscription Agreement for the PIPE Investment, the Issuer has agreed to issue additional shares of Class A Common Stock if the volume weighted average price per share of Class A Common Stock during the 30-day period (the "Adjustment Period") commencing on the date that is 30 days after the date on which a resale Registration Statement relating to the PIPE Investment is declared effective (the "Adjustment Period VWAP") is less than $10.00 per share. In such case, the Sponsor will be entitled to receive a number of shares of Class A Common Stock equal to the product of (x) the number of PIPE Shares held by the Sponsor through the end of the Adjustment Period multiplied by (y) a fraction, (A) the numerator of which is $10.00 minus the Adjustment Period VWAP and (B) the denominator of which is the Adjustment Period VWAP (the "Make-Whole Shares"). In the event that the Adjustment Period VWAP is less than $7.00, the Adjustment Period VWAP will be deemed to be $7.00. F3: Pursuant to a Subscription Agreement, the Reporting Person purchased 199,737 shares of Class A Common Stock in connection with the closing of the Business Combination for aggregate consideration of $1,997,370, consisting of the forgiveness of certain indebtedness and certain expense reimbursement obligations owed by the Issuer to the Sponsor and its members (the "PIPE Investment" and such shares, the "PIPE Shares"). In connection with the entry into the Subscription Agreement, the Target issued the Reporting Person a warrant 272,454 warrants to purchase 272,454 shares of common stock of the Target. Such warrant was net exercised for 272,182 shares of common stock of the Target in connection with the closing of the Subscription Agreement, which occurred substantially concurrently with the Closing. Such 272,454 shares of common stock of the Target were automatically converted into 272,182 shares of Class A Common Stock upon the Closing. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Issuer's de-registration as a Cayman Islands exempted company and domestication as a Delaware corporation (the "Domestication") in connection with the closing (the "Closing") of the Issuer's initial business combination (the "Business Combination"; the Issuer prior to the Domestication, "Chavant") with Mobix Labs, Inc. (the "Target") on December 21, 2023, each ordinary share of Chavant ("Ordinary Share") and each private placement warrant, exercisable to purchase one Ordinary Share for $11.50 per share, subject to certain adjustments, of Chavant ("Chavant Private Placement Warrants") was automatically converted into one share of Class A Common Stock of the Issuer ("Class A Common Stock") and one private placement warrant, exercisable to purchase one share of Class A Common Stock for $11.50 per share, subject to certain adjustments, of the Issuer ("Private Placement Warrants"), respectively. In connection with the Closing, Chavant was renamed "Mobix Labs, Inc."
F2: Represents a forfeiture of 658,631 Ordinary Shares held by the Sponsor in connection with the Closing (the "Share Forfeiture").
F3: Pursuant to a Subscription Agreement, the Reporting Person purchased 199,737 shares of Class A Common Stock in connection with the closing of the Business Combination for aggregate consideration of $1,997,370, consisting of the forgiveness of certain indebtedness and certain expense reimbursement obligations owed by the Issuer to the Sponsor and its members (the "PIPE Investment" and such shares, the "PIPE Shares"). In connection with the entry into the Subscription Agreement, the Target issued the Reporting Person a warrant 272,454 warrants to purchase 272,454 shares of common stock of the Target. Such warrant was net exercised for 272,182 shares of common stock of the Target in connection with the closing of the Subscription Agreement, which occurred substantially concurrently with the Closing. Such 272,454 shares of common stock of the Target were automatically converted into 272,182 shares of Class A Common Stock upon the Closing.
F4: Represents a pro rata distribution of 2,394,332 Private Placement Warrants to members of the Reporting Person in respect of their indirect interests in such Private Placement Warrants. Such Private Placement Warrants had been held by the Reporting Person as Chavant Private Placement Warrants since the initial public offering of the Issuer. Private Placement Warrants may be exercised 30 days after the Closing and expire five years after Closing or earlier upon liquidation. Balance of securities following the distribution described above reflects the forfeiture of 400,000 Private Placement Warrants in connection with the Closing of the Business Combination.
F5: Pursuant to the Subscription Agreement for the PIPE Investment, the Issuer has agreed to issue additional shares of Class A Common Stock if the volume weighted average price per share of Class A Common Stock during the 30-day period (the "Adjustment Period") commencing on the date that is 30 days after the date on which a resale Registration Statement relating to the PIPE Investment is declared effective (the "Adjustment Period VWAP") is less than $10.00 per share. In such case, the Sponsor will be entitled to receive a number of shares of Class A Common Stock equal to the product of (x) the number of PIPE Shares held by the Sponsor through the end of the Adjustment Period multiplied by (y) a fraction, (A) the numerator of which is $10.00 minus the Adjustment Period VWAP and (B) the denominator of which is the Adjustment Period VWAP (the "Make-Whole Shares"). In the event that the Adjustment Period VWAP is less than $7.00, the Adjustment Period VWAP will be deemed to be $7.00.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 21, 2023 Filed Dec 26, 2023 23:01 UTC | MOBIX LABS, INC MOBX · Entity 7651 | OtherMake-Whole Shares (right to acquire) · Derivative | 199,737 | Not disclosed Strike: $10.00 | Not disclosed |
DisclosureSEC source: 0001104659-23-129312 · tm2333669-18_4seq1.xml · derivative · entry 5 Chavant Capital Partners LLC · CIK 0001855211 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 199,737 Underlying: Class A Common Stock · 199,737 shares Expires not disclosed F5 · kind: Pursuant to the Subscription Agreement for the PIPE Investment, the Issuer has agreed to issue additional shares of Class A Common Stock if the volume weighted average price per share of Class A Common Stock during the 30-day period (the "Adjustment Period") commencing on the date that is 30 days after the date on which a resale Registration Statement relating to the PIPE Investment is declared effective (the "Adjustment Period VWAP") is less than $10.00 per share. In such case, the Sponsor will be entitled to receive a number of shares of Class A Common Stock equal to the product of (x) the number of PIPE Shares held by the Sponsor through the end of the Adjustment Period multiplied by (y) a fraction, (A) the numerator of which is $10.00 minus the Adjustment Period VWAP and (B) the denominator of which is the Adjustment Period VWAP (the "Make-Whole Shares"). In the event that the Adjustment Period VWAP is less than $7.00, the Adjustment Period VWAP will be deemed to be $7.00. F3 · price: Pursuant to a Subscription Agreement, the Reporting Person purchased 199,737 shares of Class A Common Stock in connection with the closing of the Business Combination for aggregate consideration of $1,997,370, consisting of the forgiveness of certain indebtedness and certain expense reimbursement obligations owed by the Issuer to the Sponsor and its members (the "PIPE Investment" and such shares, the "PIPE Shares"). In connection with the entry into the Subscription Agreement, the Target issued the Reporting Person a warrant 272,454 warrants to purchase 272,454 shares of common stock of the Target. Such warrant was net exercised for 272,182 shares of common stock of the Target in connection with the closing of the Subscription Agreement, which occurred substantially concurrently with the Closing. Such 272,454 shares of common stock of the Target were automatically converted into 272,182 shares of Class A Common Stock upon the Closing. F5 · price: Pursuant to the Subscription Agreement for the PIPE Investment, the Issuer has agreed to issue additional shares of Class A Common Stock if the volume weighted average price per share of Class A Common Stock during the 30-day period (the "Adjustment Period") commencing on the date that is 30 days after the date on which a resale Registration Statement relating to the PIPE Investment is declared effective (the "Adjustment Period VWAP") is less than $10.00 per share. In such case, the Sponsor will be entitled to receive a number of shares of Class A Common Stock equal to the product of (x) the number of PIPE Shares held by the Sponsor through the end of the Adjustment Period multiplied by (y) a fraction, (A) the numerator of which is $10.00 minus the Adjustment Period VWAP and (B) the denominator of which is the Adjustment Period VWAP (the "Make-Whole Shares"). In the event that the Adjustment Period VWAP is less than $7.00, the Adjustment Period VWAP will be deemed to be $7.00. F5 · derivative.exercise_date: Pursuant to the Subscription Agreement for the PIPE Investment, the Issuer has agreed to issue additional shares of Class A Common Stock if the volume weighted average price per share of Class A Common Stock during the 30-day period (the "Adjustment Period") commencing on the date that is 30 days after the date on which a resale Registration Statement relating to the PIPE Investment is declared effective (the "Adjustment Period VWAP") is less than $10.00 per share. In such case, the Sponsor will be entitled to receive a number of shares of Class A Common Stock equal to the product of (x) the number of PIPE Shares held by the Sponsor through the end of the Adjustment Period multiplied by (y) a fraction, (A) the numerator of which is $10.00 minus the Adjustment Period VWAP and (B) the denominator of which is the Adjustment Period VWAP (the "Make-Whole Shares"). In the event that the Adjustment Period VWAP is less than $7.00, the Adjustment Period VWAP will be deemed to be $7.00. F5 · derivative.expiration_date: Pursuant to the Subscription Agreement for the PIPE Investment, the Issuer has agreed to issue additional shares of Class A Common Stock if the volume weighted average price per share of Class A Common Stock during the 30-day period (the "Adjustment Period") commencing on the date that is 30 days after the date on which a resale Registration Statement relating to the PIPE Investment is declared effective (the "Adjustment Period VWAP") is less than $10.00 per share. In such case, the Sponsor will be entitled to receive a number of shares of Class A Common Stock equal to the product of (x) the number of PIPE Shares held by the Sponsor through the end of the Adjustment Period multiplied by (y) a fraction, (A) the numerator of which is $10.00 minus the Adjustment Period VWAP and (B) the denominator of which is the Adjustment Period VWAP (the "Make-Whole Shares"). In the event that the Adjustment Period VWAP is less than $7.00, the Adjustment Period VWAP will be deemed to be $7.00. F5 · derivative.underlying_shares: Pursuant to the Subscription Agreement for the PIPE Investment, the Issuer has agreed to issue additional shares of Class A Common Stock if the volume weighted average price per share of Class A Common Stock during the 30-day period (the "Adjustment Period") commencing on the date that is 30 days after the date on which a resale Registration Statement relating to the PIPE Investment is declared effective (the "Adjustment Period VWAP") is less than $10.00 per share. In such case, the Sponsor will be entitled to receive a number of shares of Class A Common Stock equal to the product of (x) the number of PIPE Shares held by the Sponsor through the end of the Adjustment Period multiplied by (y) a fraction, (A) the numerator of which is $10.00 minus the Adjustment Period VWAP and (B) the denominator of which is the Adjustment Period VWAP (the "Make-Whole Shares"). In the event that the Adjustment Period VWAP is less than $7.00, the Adjustment Period VWAP will be deemed to be $7.00. Read SEC document |
| December 21, 2023 Filed Dec 26, 2023 23:01 UTC | MOBIX LABS, INC MOBX · Entity 7651 | OtherPrivate Placement Warrants · Derivative | 2,394,332 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0001104659-23-129312 · tm2333669-18_4seq1.xml · derivative · entry 4 Chavant Capital Partners LLC · CIK 0001855211 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 2,394,332 shares Expires 2028-12-21 F1 · security: Pursuant to the Issuer's de-registration as a Cayman Islands exempted company and domestication as a Delaware corporation (the "Domestication") in connection with the closing (the "Closing") of the Issuer's initial business combination (the "Business Combination"; the Issuer prior to the Domestication, "Chavant") with Mobix Labs, Inc. (the "Target") on December 21, 2023, each ordinary share of Chavant ("Ordinary Share") and each private placement warrant, exercisable to purchase one Ordinary Share for $11.50 per share, subject to certain adjustments, of Chavant ("Chavant Private Placement Warrants") was automatically converted into one share of Class A Common Stock of the Issuer ("Class A Common Stock") and one private placement warrant, exercisable to purchase one share of Class A Common Stock for $11.50 per share, subject to certain adjustments, of the Issuer ("Private Placement Warrants"), respectively. In connection with the Closing, Chavant was renamed "Mobix Labs, Inc." F4 · kind: Represents a pro rata distribution of 2,394,332 Private Placement Warrants to members of the Reporting Person in respect of their indirect interests in such Private Placement Warrants. Such Private Placement Warrants had been held by the Reporting Person as Chavant Private Placement Warrants since the initial public offering of the Issuer. Private Placement Warrants may be exercised 30 days after the Closing and expire five years after Closing or earlier upon liquidation. Balance of securities following the distribution described above reflects the forfeiture of 400,000 Private Placement Warrants in connection with the Closing of the Business Combination. F4 · price: Represents a pro rata distribution of 2,394,332 Private Placement Warrants to members of the Reporting Person in respect of their indirect interests in such Private Placement Warrants. Such Private Placement Warrants had been held by the Reporting Person as Chavant Private Placement Warrants since the initial public offering of the Issuer. Private Placement Warrants may be exercised 30 days after the Closing and expire five years after Closing or earlier upon liquidation. Balance of securities following the distribution described above reflects the forfeiture of 400,000 Private Placement Warrants in connection with the Closing of the Business Combination. F4 · balance_after: Represents a pro rata distribution of 2,394,332 Private Placement Warrants to members of the Reporting Person in respect of their indirect interests in such Private Placement Warrants. Such Private Placement Warrants had been held by the Reporting Person as Chavant Private Placement Warrants since the initial public offering of the Issuer. Private Placement Warrants may be exercised 30 days after the Closing and expire five years after Closing or earlier upon liquidation. Balance of securities following the distribution described above reflects the forfeiture of 400,000 Private Placement Warrants in connection with the Closing of the Business Combination. Read SEC document |
| December 21, 2023 Filed Dec 26, 2023 23:01 UTC | MOBIX LABS, INC MOBX · Entity 7651 | OtherClass A Common Stock | 272,182 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-23-129312 · tm2333669-18_4seq1.xml · nonDerivative · entry 3 Chavant Capital Partners LLC · CIK 0001855211 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,394,101 F1 · security: Pursuant to the Issuer's de-registration as a Cayman Islands exempted company and domestication as a Delaware corporation (the "Domestication") in connection with the closing (the "Closing") of the Issuer's initial business combination (the "Business Combination"; the Issuer prior to the Domestication, "Chavant") with Mobix Labs, Inc. (the "Target") on December 21, 2023, each ordinary share of Chavant ("Ordinary Share") and each private placement warrant, exercisable to purchase one Ordinary Share for $11.50 per share, subject to certain adjustments, of Chavant ("Chavant Private Placement Warrants") was automatically converted into one share of Class A Common Stock of the Issuer ("Class A Common Stock") and one private placement warrant, exercisable to purchase one share of Class A Common Stock for $11.50 per share, subject to certain adjustments, of the Issuer ("Private Placement Warrants"), respectively. In connection with the Closing, Chavant was renamed "Mobix Labs, Inc." F3 · kind: Pursuant to a Subscription Agreement, the Reporting Person purchased 199,737 shares of Class A Common Stock in connection with the closing of the Business Combination for aggregate consideration of $1,997,370, consisting of the forgiveness of certain indebtedness and certain expense reimbursement obligations owed by the Issuer to the Sponsor and its members (the "PIPE Investment" and such shares, the "PIPE Shares"). In connection with the entry into the Subscription Agreement, the Target issued the Reporting Person a warrant 272,454 warrants to purchase 272,454 shares of common stock of the Target. Such warrant was net exercised for 272,182 shares of common stock of the Target in connection with the closing of the Subscription Agreement, which occurred substantially concurrently with the Closing. Such 272,454 shares of common stock of the Target were automatically converted into 272,182 shares of Class A Common Stock upon the Closing. F3 · price: Pursuant to a Subscription Agreement, the Reporting Person purchased 199,737 shares of Class A Common Stock in connection with the closing of the Business Combination for aggregate consideration of $1,997,370, consisting of the forgiveness of certain indebtedness and certain expense reimbursement obligations owed by the Issuer to the Sponsor and its members (the "PIPE Investment" and such shares, the "PIPE Shares"). In connection with the entry into the Subscription Agreement, the Target issued the Reporting Person a warrant 272,454 warrants to purchase 272,454 shares of common stock of the Target. Such warrant was net exercised for 272,182 shares of common stock of the Target in connection with the closing of the Subscription Agreement, which occurred substantially concurrently with the Closing. Such 272,454 shares of common stock of the Target were automatically converted into 272,182 shares of Class A Common Stock upon the Closing. Read SEC document |
| December 21, 2023 Filed Dec 26, 2023 23:01 UTC | MOBIX LABS, INC MOBX · Entity 7651 | PurchaseClass A Common Stock | 199,737 | $10.00 | $1,997,370.00 |
DisclosureSEC source: 0001104659-23-129312 · tm2333669-18_4seq1.xml · nonDerivative · entry 2 Chavant Capital Partners LLC · CIK 0001855211 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,121,919 F1 · security: Pursuant to the Issuer's de-registration as a Cayman Islands exempted company and domestication as a Delaware corporation (the "Domestication") in connection with the closing (the "Closing") of the Issuer's initial business combination (the "Business Combination"; the Issuer prior to the Domestication, "Chavant") with Mobix Labs, Inc. (the "Target") on December 21, 2023, each ordinary share of Chavant ("Ordinary Share") and each private placement warrant, exercisable to purchase one Ordinary Share for $11.50 per share, subject to certain adjustments, of Chavant ("Chavant Private Placement Warrants") was automatically converted into one share of Class A Common Stock of the Issuer ("Class A Common Stock") and one private placement warrant, exercisable to purchase one share of Class A Common Stock for $11.50 per share, subject to certain adjustments, of the Issuer ("Private Placement Warrants"), respectively. In connection with the Closing, Chavant was renamed "Mobix Labs, Inc." F3 · kind: Pursuant to a Subscription Agreement, the Reporting Person purchased 199,737 shares of Class A Common Stock in connection with the closing of the Business Combination for aggregate consideration of $1,997,370, consisting of the forgiveness of certain indebtedness and certain expense reimbursement obligations owed by the Issuer to the Sponsor and its members (the "PIPE Investment" and such shares, the "PIPE Shares"). In connection with the entry into the Subscription Agreement, the Target issued the Reporting Person a warrant 272,454 warrants to purchase 272,454 shares of common stock of the Target. Such warrant was net exercised for 272,182 shares of common stock of the Target in connection with the closing of the Subscription Agreement, which occurred substantially concurrently with the Closing. Such 272,454 shares of common stock of the Target were automatically converted into 272,182 shares of Class A Common Stock upon the Closing. F3 · price: Pursuant to a Subscription Agreement, the Reporting Person purchased 199,737 shares of Class A Common Stock in connection with the closing of the Business Combination for aggregate consideration of $1,997,370, consisting of the forgiveness of certain indebtedness and certain expense reimbursement obligations owed by the Issuer to the Sponsor and its members (the "PIPE Investment" and such shares, the "PIPE Shares"). In connection with the entry into the Subscription Agreement, the Target issued the Reporting Person a warrant 272,454 warrants to purchase 272,454 shares of common stock of the Target. Such warrant was net exercised for 272,182 shares of common stock of the Target in connection with the closing of the Subscription Agreement, which occurred substantially concurrently with the Closing. Such 272,454 shares of common stock of the Target were automatically converted into 272,182 shares of Class A Common Stock upon the Closing. Read SEC document |
| December 21, 2023 Filed Dec 26, 2023 23:01 UTC | MOBIX LABS, INC MOBX · Entity 7651 | OtherClass A Common Stock | 658,631 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-129312 · tm2333669-18_4seq1.xml · nonDerivative · entry 1 Chavant Capital Partners LLC · CIK 0001855211 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 922,182 F1 · security: Pursuant to the Issuer's de-registration as a Cayman Islands exempted company and domestication as a Delaware corporation (the "Domestication") in connection with the closing (the "Closing") of the Issuer's initial business combination (the "Business Combination"; the Issuer prior to the Domestication, "Chavant") with Mobix Labs, Inc. (the "Target") on December 21, 2023, each ordinary share of Chavant ("Ordinary Share") and each private placement warrant, exercisable to purchase one Ordinary Share for $11.50 per share, subject to certain adjustments, of Chavant ("Chavant Private Placement Warrants") was automatically converted into one share of Class A Common Stock of the Issuer ("Class A Common Stock") and one private placement warrant, exercisable to purchase one share of Class A Common Stock for $11.50 per share, subject to certain adjustments, of the Issuer ("Private Placement Warrants"), respectively. In connection with the Closing, Chavant was renamed "Mobix Labs, Inc." F2 · kind: Represents a forfeiture of 658,631 Ordinary Shares held by the Sponsor in connection with the Closing (the "Share Forfeiture"). Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 16:45 UTC | MOBIX LABS, INC CLAY · Entity 7651 | GrantOrdinary Shares | 18,782 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-027837 · tm227631-7_4.xml · nonDerivative · entry 1 Chavant Capital Partners LLC · CIK 0001855211 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,580,814 F1 · shares: The ordinary shares are described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-257459) (the "Registration Statement") and have no expiration date. On February 24, 2022, the Reporting Person acquired 18,782 ordinary shares from certain directors and officers of Chavant Capital Acquisition Corp. for no consideration. F1 · price: The ordinary shares are described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-257459) (the "Registration Statement") and have no expiration date. On February 24, 2022, the Reporting Person acquired 18,782 ordinary shares from certain directors and officers of Chavant Capital Acquisition Corp. for no consideration. Read SEC document |
| September 20, 2021 Filed Sep 21, 2021 23:49 UTC | MOBIX LABS, INC CLAY · Entity 7651 | Disposition to issuerOrdinary Shares | 255,903 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-118025 · tm2128151-2_4.xml · nonDerivative · entry 1 Chavant Capital Partners LLC · CIK 0001855211 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,562,032 F1 · shares: The ordinary shares are described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-257459) (the "Registration Statement") and have no expiration date. On September 20, 2021, in connection with the expiration of the underwriters' over-allotment option originally granted to the underwriters in connection with the Issuer's initial public offering of units, as described in the Registration Statement, the Reporting Person surrendered 255,903 ordinary shares to the Issuer. F1 · price: The ordinary shares are described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-257459) (the "Registration Statement") and have no expiration date. On September 20, 2021, in connection with the expiration of the underwriters' over-allotment option originally granted to the underwriters in connection with the Issuer's initial public offering of units, as described in the Registration Statement, the Reporting Person surrendered 255,903 ordinary shares to the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.